| dc.contributor.author | Baliga, RS | en_US |
| dc.contributor.author | Scotton, CJ | en_US |
| dc.contributor.author | Trinder, SL | en_US |
| dc.contributor.author | Chambers, RC | en_US |
| dc.contributor.author | MacAllister, RJ | en_US |
| dc.contributor.author | Hobbs, AJ | en_US |
| dc.date.accessioned | 2016-08-19T15:43:22Z | |
| dc.date.available | 2014-03-11 | en_US |
| dc.date.issued | 2014-07 | en_US |
| dc.date.submitted | 2016-07-21T14:00:47.984Z | |
| dc.identifier.issn | 0007-1188 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14814 | |
| dc.description.sponsorship | This work was supported by the British Lung Foundation.
C.J.S. is supported by a Medical Research Council Fellowship. | en_US |
| dc.format.extent | 3463 - 3475 | en_US |
| dc.relation.ispartof | BRITISH JOURNAL OF PHARMACOLOGY | en_US |
| dc.rights | This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | |
| dc.subject | natriuretic peptide | en_US |
| dc.subject | neutral endopeptidase | en_US |
| dc.subject | guanylyl cyclase | en_US |
| dc.subject | cyclic GMP | en_US |
| dc.subject | pulmonary hypertension | en_US |
| dc.subject | phosphodiesterase | en_US |
| dc.subject | bleomycin | en_US |
| dc.title | Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2014 The Authors. | |
| dc.identifier.doi | 10.1111/bph.12694 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338123100010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 14 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 171 | en_US |
